NPI registry status
Active
2026 NPPES data Interventional Pain Medicine Physician NPI 1093134983 M.D.
Verify on CMS → Matthew Bergsten, M.D.
Interventional Pain Medicine Physician in Albuquerque, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,528 in Interventional Pain Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 379 beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$510.77
35 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Matthew Bergsten, M.D. filed 3,281 Medicare Part D claims in 2023 as a Interventional Pain Medicine Physician in Albuquerque, New Mexico, prescribing 95% generic.
- 3K
- Part D claims, 2023
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Matthew Bergsten, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
3,281 Top 11% higher than 89% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Matthew Bergsten, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Bergsten, M.D.?
Quality data not reportedPrimary specialty
Interventional Pain Medicine Physician
Medicare Part D claims
3,281 49% vs specialty avg
Specialty distribution in New Mexico
How Interventional Pain Medicine Physician compares to other specialties among New Mexico providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Interventional Pain Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Matthew Bergsten, M.D. appears in the CMS NPPES registry as a Interventional Pain Medicine Physician provider holding M.D. credentials at 8501 CANDELARIA RD NE STE E, Albuquerque, NM, 87112, with a listed phone of (505) 420-4971. NPI 1093134983 was issued on 04/08/2014.
Medicare Part D records for calendar year 2023 show 3,281 prescription claims written by this provider, covering 379 Medicare beneficiaries and totaling roughly $236K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 31.8%.
Interventional Pain Medicine Physician is a narrow specialty nationwide, with 1,528 enrolled providers across 53 states and an average of 2,197 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093134983 |
|---|---|
| Specialty | Interventional Pain Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/08/2014 |
Hospital and facility affiliations
Facilities where Matthew Bergsten, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Sandia Pain Center LLC
Albuquerque, NM
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Bergsten, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$511
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Matthew Bergsten, M.D. - brand share 5.0%
Interventional Pain Medicine Physician average
5% brand-name claims vs 95% generic, on 3,281 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,281
Total Claims
$236K
Total Drug Cost
379
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,503
- Total Day Supply
- 97,327
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $119K
- Generic Drug Cost
- $117K
- Opioid Claims
- 1,044 (31.8% rate)
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 67.2 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 123, 65-74: 154, 75-84: 86, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Matthew Bergsten, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
445 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
418 claims
- Pregabalin
Pregabalin
406 claims
- Tramadol Hcl
Tramadol Hcl
222 claims
- Buprenorphine Hcl 175
Buprenorphine Hcl
175 claims
- Acetaminophen-Code… 159
Acetaminophen-Codeine
159 claims
- Meloxicam 110
Meloxicam
110 claims
- Tizanidine Hcl 109
Tizanidine Hcl
109 claims
| Drug | Claims |
|---|---|
| Gabapentin | 445 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 418 |
| Pregabalin | 406 |
| Tramadol Hcl | 222 |
| Buprenorphine Hcl | 175 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 159 |
| Meloxicam | 110 |
| Tizanidine Hcl | 109 |
| Cyclobenzaprine Hcl | 86 |
| Methocarbamol | 84 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Interventional Pain Medicine Physician in NM →
All providers in New Mexico →
Compare specialties →
Interventional Pain Medicine Physician Overview
How Matthew Bergsten, M.D. fits within the Interventional Pain Medicine Physician landscape nationally.
1,528
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,197
Avg Claims per Provider
Matthew Bergsten, M.D.'s 3,281 claims are above the specialty average of 2,197.
Nearby Interventional Pain Medicine Physician Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Bergsten.
Dr. Radhika Grandhe
MBBS, FRCA, MD
Albuquerque, NM
Dr. Craig Nairn
M.D.
Albuquerque, NM
Dr. Kyle Schoenberger
NP
Albuquerque, NM
Dr. Jonas Skardis
DOM
Santa Fe, NM
Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Mexico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Interventional Pain Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New Mexico
Frequently Asked Questions
What is Matthew Bergsten, M.D.'s specialty? ▼
Matthew Bergsten, M.D. specializes in Interventional Pain Medicine Physician and practices in Albuquerque, New Mexico. Credentials: M.D..
How much does Matthew Bergsten, M.D. prescribe under Medicare Part D? ▼
In 2023, Matthew Bergsten, M.D. wrote 3,281 Medicare Part D claims totaling $236K in drug costs for 379 beneficiaries.
Where is Matthew Bergsten, M.D. located? ▼
Matthew Bergsten, M.D. is located at 8501 CANDELARIA RD NE STE E, Albuquerque, NM, 87112. Phone: (505) 420-4971.
What is Matthew Bergsten, M.D.'s NPI number? ▼
Matthew Bergsten, M.D.'s National Provider Identifier (NPI) is 1093134983, issued on 04/08/2014.
Does Matthew Bergsten, M.D. prescribe more brand-name or generic drugs? ▼
Matthew Bergsten, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $119K in brand drug costs.
Does Matthew Bergsten, M.D. prescribe opioids? ▼
Yes, Matthew Bergsten, M.D. had 1,044 opioid claims in 2023 with an opioid prescribing rate of 31.8%.
How many Interventional Pain Medicine Physician providers are there in the US? ▼
There are 1,528 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,197 Medicare Part D claims per year.
What drugs does Matthew Bergsten, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Matthew Bergsten, M.D.'s most frequently prescribed drugs include Gabapentin, Hydrocodone-Acetaminophen, Pregabalin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Bergsten, M.D. accept Medicare? ▼
Matthew Bergsten, M.D. appears in CMS Medicare data with 3,281 Part D claims and 379 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Bergsten, M.D.'s credentials? ▼
Matthew Bergsten, M.D.'s NPI is 1093134983 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.